Ostomy Drainage Bags Devices Market

Increase in inflammatory bowel disease cases is driving the market growth

Market CAGR for ostomy drainage bags devices is being driven by an increase in inflammatory bowel disease cases. An artificial opening, or stoma, is surgically created in the human colon during an ostomy treatment to remove waste materials such feces, mucus, and urine. Ostomy drainage bags are pouches or bags made of plastic or rubber that is used to collect these wastes. One-piece systems and two-piece systems are the two sorts of bags.

Additionally, colorectal, bladder, and inflammatory bowel cancers are the most common disorders requiring ostomy surgery. Inflammatory bowel disease (IBD) is also expected to fuel market expansion, as is the surgical removal of a malignant tumor or a portion of the intestines in the treatment of colorectal cancer. Ostomy drainage bags will be more in demand as the number of elderly people with colorectal cancer rises. This will further accelerate market growth as the base of the senior population, defined as those 80 years of age and above, is predicted to rise at a significantly higher rate than the younger population.

The development of new goods through increased research and development is contributing to the growth of the market. Furthermore, it is predicted that growing medical tourism and rising internet usage for online shopping would present prospects for the ostomy drainage bag market to expand in the upcoming years. However, it is also anticipated that the challenges associated with ostomy and the rising use of alternative therapies may hinder the market expansion for ostomy drainage bags during the intended time frame.

However, the disparities in ostomy supply reimbursement in developing nations may pose additional obstacles to the market expansion for ostomy drainage bags in the near future.

For instance, the incidence of Crohn's disease (CD), ulcerative colitis (UC), and inflammatory bowel disease (IBD) was determined to be 28.6, 10.2, and 15.7/100,000 people in the United Kingdom, according to a research study by Thomas Joshua Pasvol et al. that was published in the BMC Journal in August 2020. Furthermore, from 13.1 per 100,000 people in 2000 to 25.4 per 100,000 people in 2018, the incidence of inflammatory bowel disease (IBD) rose among teenagers aged 10 to 16. Thus, result in driving the Ostomy Drainage Bags Devices market revenue.

There is a notable increase in awareness and acceptance of ostomy procedures, which is positively affecting the Global Ostomy Drainage Bags Devices Market Industry. Educational initiatives by healthcare organizations and support groups are helping to destigmatize ostomy surgeries, encouraging more patients to seek necessary treatments. This cultural shift is likely to lead to higher adoption rates of ostomy products. As awareness continues to grow, the market is expected to expand, with projections indicating a rise to 3.05 USD Billion by 2035, highlighting the importance of education in driving market growth.

The Global Ostomy Drainage Bags Devices Market Industry is experiencing growth due to the increasing prevalence of chronic diseases such as colorectal cancer, inflammatory bowel disease, and diverticulitis. As these conditions necessitate surgical interventions leading to ostomy procedures, the demand for ostomy drainage bags is likely to rise. For instance, the World Health Organization indicates that colorectal cancer cases are projected to increase, thereby driving the need for ostomy solutions. This trend is expected to contribute to the market's valuation, which is anticipated to reach 1.98 USD Billion in 2024.

Innovations in the design and functionality of ostomy drainage bags are significantly influencing the Global Ostomy Drainage Bags Devices Market Industry. Manufacturers are increasingly focusing on developing products that enhance user comfort, reduce leakage, and improve skin protection. For example, advancements in adhesive technologies and the introduction of odor-control features are becoming prevalent. These enhancements not only improve the quality of life for users but also expand the market reach. As a result, the market is projected to grow at a CAGR of 4.0% from 2025 to 2035, reflecting the positive impact of these technological developments.

The Global Ostomy Drainage Bags Devices Market Industry is benefiting from improved distribution channels and increased accessibility to ostomy products. E-commerce platforms and specialized medical supply stores are making it easier for patients to obtain necessary supplies. This enhanced accessibility is crucial for individuals who may have difficulty accessing traditional healthcare facilities. As distribution networks expand and online purchasing becomes more prevalent, the market is likely to see increased sales and a broader customer base, further driving growth.

The aging global population is a significant driver of the Global Ostomy Drainage Bags Devices Market Industry. Older adults are more susceptible to conditions requiring ostomy surgeries, leading to an increased demand for ostomy drainage bags. According to demographic studies, the proportion of individuals aged 65 and older is expected to rise, correlating with a higher incidence of surgeries. This demographic trend suggests that manufacturers must prepare for a growing market, as the need for ostomy solutions becomes more pronounced in the coming years.

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The North American Ostomy Drainage Bags Devices market area will dominate this market, because modern healthcare technologies are so widely used. Moreover, throughout the projected period, the rise in cancer cases will support the expansion of the ostomy drainage bag market in the area.

Further, the major countries studied in the market report are The US, German, France, the UK, Canada, Italy, Spain, India, Australia, South Korea, China, Japan, and Brazil.

Figure2: Ostomy Drainage Bags Devices Market Share By Region 2022 (USD Billion)

Source: Secondary Research, Primary Research, Market Research Future Database and Analyst Review

Europe Ostomy Drainage Bags Devices market has the second-largest portion of the market, since the incidence of serious illnesses in the area is on the rise. Further, the German Ostomy Drainage Bags Devices market held the largest proportion of the market, and the UK Ostomy Drainage Bags Devices market was the European market with the quickest rate of growth.

The Asia-Pacific Ostomy Drainage Bags Devices Market has the quickest predicted compound annual growth rate (CAGR) between 2023 and 2032. This is due to the aging population and rising healthcare infrastructure development costs. Moreover, China’s Ostomy Drainage Bags Devices market had the biggest market share, and the Indian Ostomy Drainage Bags Devices market was the Asia-Pacific region's fastest-growing market.

Leading market players are putting a lot of money on R&D to expand their product lines, which will drive the market for ostomy drainage bag devices to continue growing. Additionally, market players are engaging in a range of calculated initiatives to increase their worldwide presence, with important market developments involving the introduction of new products, contracts, M&A transactions, increased investment, and cooperation with other enterprises. To grow and endure in an increasingly cutthroat and dynamic market, Ostomy Drainage Bags Devices industry must provide reasonably priced goods.

Manufacturing locally is one of the primary business techniques used by manufacturers to cut operational costs in the Ostomy Drainage Bags Devices industry to help customers and expand the market segment. In recent years, the Ostomy Drainage Bags Devices industry has provided some of the biggest benefits to medicine. Major players in the Ostomy Drainage Bags Devices market, including ALCARE Co., Ltd. (Japan), B. Braun Melsungen AG (Germany), Coloplast (Denmark), ConvaTec Inc. (UK), Flexicare (Group) Limited (UK), and others, are engaging in research and development activities in an effort to boost market demand.

Coloplast A/S develops, produces, and sells ostomy, urology, continence, and wound care products and services. Aage Louis-Hansen founded Coloplast in 1957. Niels Peter Louis-Hansen, his son, is the deputy chairman and holds 20% of the corporation. With production facilities in Denmark, Hungary, France, China, and the US, and sales operations in 53 countries, the company employs over 12,000 people worldwide. Its  headquarters are located in Denmark's Humlebaek. In November 2021, Coloplast declared that it would pay 2.16 billion euros ($2.49 billion) to purchase Atos Medical and its laryngectomy technology.

Convatec Group plc is a firm that provides medical products and technologies. Its offerings include advanced wound care, ostomy care, continence care, and infusion care. The London Stock Exchange lists it, and it is a part of the FTSE 100 Index. The business was taken over by Nordic Capital and Avista Capital Partners in 2008. It was first founded in 1978 as a division of E.R. Squibb & Sons, Inc. amalgamated in 2008 with the Danish-based maker of single-use medical equipment, Unomedical, then in 2012 with the catheter manufacturer, 180 Medical.

In August 2019, On the same day that Karim Bitar was appointed CEO, Convatec announced that Dr. John McAdam CBE will take over as Chairman, effective September 30.